This article is from the WebMD Feature Archive
Addiction: Life in a Bottle
As an aspiring novelist in his early 20s, Carl (not his real name) equated the glamorous life of writing with boozing.
"Faulkner, Hemingway, Fitzgerald, and more contemporary writers were known as big boozers. If it was good for them, why can't it be good for me?" he thought.
But he didn't get the results that he wanted when he drank. The words wouldn't flow and plus, he realized that his attitudes related with drinking and writing had isolated him from the rest of society.
Because he felt "too good" for the mainstream work-world while he was an alcoholic, he thumbed his nose at an admission to law school, and didn't initially seek employment that would make use of his master's degree in writing. Instead, he worked as a taxi driver and eventually as an editorial assistant for a publishing company to make ends meet.
It wasn't until he started going to Alcoholics Anonymous (AA) meetings that Carl recognized how self-destructive he had become -- getting drunk with his passengers as a cabbie and calling in sick as an editorial assistant to cure a hangover or to quench his thirst for drink.
When he became sober, Carl felt a lot better about himself and felt a sense of belonging with the rest of the world.
"I began to bring my full energy to the workplace, and not hold myself in reserve because I was saving myself for a bigger life as a writer," says Carl, now in his 50s. He notes that his shift in attitude opened opportunities for him. He was promoted to an editor position, and one of the short stories he wrote as a hobby even won a literary award.
This story is not much different from others with addiction in that their obsession with something -- in Carl's case, alcohol -- controls their behavior and attitudes about life.
Addicts need to satisfy a hunger, and that need takes on a higher priority than other responsibilities, including work, says Lawrence S. Brown, Jr., MD, MPH, president of the American Society of Addiction Medicine.
This disregard for responsibility can be expensive for society. According to a study conducted by the National Institute on Drug Abuse (NIDA), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA), in 1995 alone, alcohol and drug abuse cost the economy an estimated $276.3 billion in decreased productivity, increased accidents, absenteeism, job turnover, and medical costs.
That figure could arguably swell once the cost for pain and suffering and other compulsive behaviors are factored in.
According to a review of studies by the Illinois Institute for Addiction Recovery, up to 3% of the U.S. population is addicted to gambling, up to 3% with food, up to 8% with spending, and 5% to sex.
Indication
Uroxatral® (alfuzosin HCl 10 mg extended-release tablets) is an alpha1-blocker for the treatment of the signs and symptoms of BPH.
Important Safety Information
Do not take UROXATRAL if you have liver problems or if you are taking antifungal drugs like ketoconazole or itraconazole, or HIV drugs like ritonavir.
UROXATRAL can cause a sudden drop in blood pressure, especially when starting treatment. This may lead to fainting, dizziness, and lightheadedness. Do not drive, operate machinery, or do any dangerous activity until you know how UROXATRAL will affect you. This is especially important if you already have a problem with low blood pressure or take medicines to treat high blood pressure. There may be an increased risk of low blood pressure and fainting when taking UROXATRAL in combination with blood pressure medication or nitrates, or erectile dysfunction medication.
If considering cataract surgery (clouding of the eyes), tell your eye surgeon that you are currently taking UROXATRAL or have previously been treated with an alpha-blocker.
Before taking UROXATRAL, tell your doctor if you have kidney problems.
Also, tell your doctor if you or any family member(s) have or take medications for a rare heart condition known as congenital prolongation of the QT interval.
BPH and prostate cancer can cause the same symptoms. However, UROXATRAL is not a treatment for prostate cancer.
The most common side effects with UROXATRAL are dizziness, upper respiratory tract infection, headache, and tiredness.
Please see UROXATRAL full prescribing information.

